- Home
- IVDA vs MIRA Comparison
IVDA vs MIRA Comparison
Compare IVDA & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- MIRA
- Stock Information
- Founded
- IVDA 2003
- MIRA 2020
- Country
- IVDA United States
- MIRA United States
- Employees
- IVDA N/A
- MIRA N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- MIRA Health Care
- Exchange
- IVDA Nasdaq
- MIRA Nasdaq
- Market Cap
- IVDA 3.5M
- MIRA 17.1M
- IPO Year
- IVDA N/A
- MIRA 2023
- Fundamental
- Price
- IVDA $1.64
- MIRA $1.05
- Analyst Decision
- IVDA
- MIRA Strong Buy
- Analyst Count
- IVDA 0
- MIRA 2
- Target Price
- IVDA N/A
- MIRA $14.00
- AVG Volume (30 Days)
- IVDA 40.0K
- MIRA 552.1K
- Earning Date
- IVDA 11-20-2024
- MIRA 11-11-2024
- Dividend Yield
- IVDA N/A
- MIRA N/A
- EPS Growth
- IVDA N/A
- MIRA N/A
- EPS
- IVDA N/A
- MIRA N/A
- Revenue
- IVDA $3,779,754.00
- MIRA N/A
- Revenue This Year
- IVDA $23.76
- MIRA N/A
- Revenue Next Year
- IVDA $229.89
- MIRA N/A
- P/E Ratio
- IVDA N/A
- MIRA N/A
- Revenue Growth
- IVDA N/A
- MIRA N/A
- 52 Week Low
- IVDA $1.40
- MIRA $0.51
- 52 Week High
- IVDA $10.16
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- IVDA 41.96
- MIRA 38.97
- Support Level
- IVDA $1.40
- MIRA $1.04
- Resistance Level
- IVDA $1.72
- MIRA $1.20
- Average True Range (ATR)
- IVDA 0.10
- MIRA 0.07
- MACD
- IVDA 0.06
- MIRA 0.02
- Stochastic Oscillator
- IVDA 75.00
- MIRA 19.44
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.